Inhibitory effects of mepacrine and eicosatetraynoic acid on cyclic GMP elevations caused by calcium and hormonal factors in rat ductus deferens.
D015117:5,8,11,14-Eicosatetraynoic Acid / Q000494:pharmacology*; D000818:Animals; D002118:Calcium / Q000494:pharmacology*; D006152:Cyclic GMP / Q000378:metabolism*; D005227:Fatty Acids / Q000378:metabolism; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology*; D006728:Hormones / Q000494:pharmacology*; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D010545:Peroxides / Q000378:metabolism; D011796:Quinacrine / Q000494:pharmacology*; D051381:Rats; D014649:Vas Deferens / Q000187:drug effects / Q000378:metabolism*
D005227:Fatty Acids; D005231:Fatty Acids, Unsaturated; D006728:Hormones; D010545:Peroxides; D015117:5,8,11,14-Eicosatetraynoic Acid; D011796:Quinacrine; D006152:Cyclic GMP; D002118:Calcium